Company Data

Alterity Therapeutics Limited

Ticker
ATHE
Current Price
$4.08 -2.63%
Market Cap
$35.7M
Price Target
Refer to Report
Volume
22.7K
52wk Range
$1.001 - $5.87
Advanced Market Data

Overview

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease, and other neurodegenerative disorders. The company’s lead drug candidate-PBT2 is being developed for the treatment of Alzheimer’s and Huntington’s diseases. It has also advanced a drug candidate for Parkinson’s disease and other movement disorders (ATH434).

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy